Chronic methamphetamine psychosis after long-term abstinence in Japanese incarcerated patients

American Journal on Addictions

Volumn 20, Issue 3, 2011, Pages 240-249

  Akiyama, Kazufumi ^a   Saito, Atsushi ^a   Shimoda, Kazutaka ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

METHAMPHETAMINE;

ADULT; AKATHISIA; ANXIETY; ARTICLE; CORRELATION ANALYSIS; DEPRESSION; DISEASE SEVERITY; DRUG ABUSE; EXTRAPYRAMIDAL SYNDROME; FEMALE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MENTAL DISEASE; PARKINSONISM; PREVALENCE; PSYCHOSIS; RECURRENT DISEASE; SCORING SYSTEM; SUICIDE ATTEMPT; TARDIVE DYSKINESIA; WITHDRAWAL SYNDROME;

ADULT; AMPHETAMINE-RELATED DISORDERS; ASIAN CONTINENTAL ANCESTRY GROUP; CHRONIC DISEASE; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; MENTAL DISORDERS; METHAMPHETAMINE; PRISONERS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RECURRENCE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 79953894399     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2011.00124.x     Document Type: Article

References (41)

1. Tatetsu S,. Methamphetamine psychosis. Folia Psychiatr Neurol Jpn. 1963; 7(Suppl): 377-380.
2. Sato M, Chen C-C, Akiyama K, Otsuki S,. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol Psychiatry. 1983; 18: 429-440. (Pubitemid 13121482)
3. Iwanami A, Sugiyama A, Kuroki N, et al,. Patients with methamphetamine psychosis admitted to a psychiatric hospital in Japan. A preliminary report. Acta Psychiatr Scand. 1994; 89: 428-432. (Pubitemid 24210089)
4. Lin S-K, Ball D, Hsiao C-C, et al,. Psychiatric comorbidity and gender differences of persons incarcerated for methamphetamine abuse in Taiwan. Psychiatry Clin Neurosci. 2004; 58: 206-212. (Pubitemid 38470545)
5. McKetin R, McLaren J, Lubman DI, et al,. The prevalence of psychotic symptoms among methamphetamine users. Addiction. 2006; 101: 1473-1478. (Pubitemid 44337772)
6. Mahoney JJ, Kalechstein AD, De La Garza R, et al,. Presence and persistence of psychotic symptoms in cocaine-versus methamphetamine-dependent participants. Am J Addict. 2008; 17: 83-98. (Pubitemid 351507725)
7. Mathias S, Lubman DI, Hides L,. Substance-induced psychosis: A diagnostic conundrum. J Clin Psychiatry. 2008; 69: 358-367. (Pubitemid 351549387)
8. Grelotti DJ, Kanayama G, Pope HG,. Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: Presentation of a case and review of the literature. Am J Psychiatry. 2010; 167: 17-23.
9. Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, et al,. Clinical course and outcomes of methamphetamine-dependent adults with psychosis. J Subst Abuse Treat. 2008; 35: 445-450.
10. Hall W, Hando J, Darke S, et al,. Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction. 1996; 91: 81-87. (Pubitemid 26026812)
11. Dore G, Sweeting M,. Drug-induced psychosis associated with crystalline methamphetamine. Australas Psychiatry. 2006; 14: 86-89.
12. Chen C-K, Lin S-K, Sham PC, et al,. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychol Med. 2003; 33: 1407-1414. (Pubitemid 37483463)
13. Yui K, Ishiguro T, Goto K, et al,. Spontaneous recurrence of methamphetamine psychosis: Increased sensitivity to stress associated with noradrenergic hyperactivity and dopaminergic change. Eur Arch Psychiatry Clin Neurosci. 1999; 249: 103-111. (Pubitemid 29366769)
14. Srisurapanont M, Ali R, Marsden J, et al,. Psychotic symptoms in methamphetamine psychotic in-patients. Int J Neuropsychopharmacol. 2003; 6: 347-352. (Pubitemid 38146252)
15. Kalechstein AD, Newton TF, Longshore D, et al,. Psychiatric comorbidity of methamphetamine dependence in a forensic sample. J Neuropsychiatry Clin Neurosci. 2000; 12: 480-484.
16. Zweben JE, Cohen JB, Christian D, et al,. Psychiatric symptoms in methamphetamine users. Am J Addict. 2004; 13: 181-190. (Pubitemid 38585698)
17. Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, et al,. Risk factors for suicide attempts in methamphetamine-dependent patients. Am J Addict. 2008; 17: 24-27. (Pubitemid 351156998)
18. Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, et al,. Identifying methamphetamine users at risk for major depressive disorder: Findings from the methamphetamine treatment project at three year follow-up. Am J Addict. 2008; 17: 99-102. (Pubitemid 351507724)
19. Darke S, Kaye S, McKetin R, et al,. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev. 2008; 27: 253-262.
20. Lukoff D, Nuechterlein KH, Ventura J,. Manual for expanded brief psychiatric rating scale (BPRS). Schizophr Bull. 1986; 12: 594-602.
21. Velligan D, Prihoda T, Dennehy E, et al,. Brief psychiatric rating scale expanded version: How do new items affect factor structure? Psychiatry Res. 2005; 135: 217-228. (Pubitemid 40984613)
22. Akiyama K,. Longitudinal clinical course following pharmacological treatment of methamphetamine psychosis which persists after long-term abstinence. Ann NY Acad Sci. 2006: 1074; 125-134. (Pubitemid 44532817)
23. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC. American Psychiatric Association; 2000.
24. Kopelowicz A, Ventura J, Liberman RP, et al,. Consistency of brief psychiatric rating scale factor structure across a broad spectrum of schizophrenia patients. Psychopathology. 2008; 41: 77-84. (Pubitemid 350308306)
25. Chen C-K, Lin S-K, Sham PC, et al,. Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis. Am J Med Genet B Neuropsychiatr Genet. 2005; 136B: 87-91. (Pubitemid 40917535)
26. Salo R, Nordahl TE, Leamon MH, et al,. Preliminary evidence of behavioral predictors of recurrent drug-induced psychosis in methamphetamine abuse. Psychiatry Res. 2008; 157: 273-277. (Pubitemid 350166555)
27. Matsumoto T, Kamijo A, Miyakawa T, et al,. Methamphetamine in Japan: The consequences of methamphetamine abuse as a function of route of administration. Addiction. 2002; 97: 809-817. (Pubitemid 34729095)
28. Farrell M, Boys A, Bebbington P, et al,. Psychosis and drug dependence: Results from a national survey of prisoners. Brit J Psychiatry. 2002; 181: 393-398. (Pubitemid 35333106)
29. Ron MA,. Volatile substance abuse: A review of possible long-term neurological, intellectual and psychiatric sequelae. Brit J Psychiatry. 1986; 148: 235-246. (Pubitemid 16036685)
30. Lerner AG, Gelkopf M, Skladman I, et al,. Flashback and hallucinogen persisting perception disorder: Clinical aspects and pharmacological treatment approach. Isr J Psychiatry Relat Sci. 2002; 39: 92-99. (Pubitemid 44394774)
31. Montross LP, Zisook S, Kasckow J,. Suicide among patients with schizophrenia: A consideration of risk and protective factors. Ann Clin Psychiatry. 2005; 17: 173-182. (Pubitemid 41176805)
32. Yen C-F, Shieh B-L,. Suicidal ideation and correlates in Taiwanese adolescent methamphetamine users. J Nerv Ment Dis. 2005; 193: 444-449. (Pubitemid 40967748)
33. Cadet JL, Brannock C,. Free radicals and the pathobiology of brain dopamine systems. Neurochem Int. 1998; 32: 117-131. (Pubitemid 28105298)
34. Volkow ND, Chang L, Wang G-J, et al,. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry. 2001; 158: 377-382. (Pubitemid 32205193)
35. Sekine Y, Iyo M, Ouchi Y, et al,. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiatry. 2001; 158: 1206-1214. (Pubitemid 32717692)
36. McCann UD, Kuwabara H, Kumar A, et al,. Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse. 2008; 62: 91-100.
37. Caligiuri MP, Buitenhuys C,. Do preclinical findings of methamphetamine-induced motor abnormalities translate to an observable clinical phenotype? Neuropsychopharmacology. 2005; 30: 2125-2134. (Pubitemid 41643963)
38. Chang L, Ernst T, Speck O, et al,. Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Res. 2002; 114: 65-79. (Pubitemid 34556681)
39. Misra L, Kofoed L,. Risperidone treatment of methamphetamine psychosis. Am J Psychiatry. 1997; 154: 1170.
40. Misra LK, Kofoed L, Oesterheld JR, et al,. Olanzapine treatment of methamphetamine psychosis. J Clin Psychopharmacol. 2000; 20: 393-394.
41. Sattar SP, Bhatia SC, Petty F,. Potential benefits of quetiapine in the treatment of substance dependence disorders. J Psychiatry Neurosci. 2004; 29: 452-457. (Pubitemid 40075716)